Welcome to our dedicated page for RRE VENTURES ACQUISITION SEC filings (Ticker: RREVU), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on RRE VENTURES ACQUISITION's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into RRE VENTURES ACQUISITION's regulatory disclosures and financial reporting.
RRE Ventures Acquisition Corp., a Cayman Islands SPAC, filed its quarterly report for the period from February 26, 2026 (inception) through March 31, 2026. The company recorded a net loss of $60,011, entirely from formation, general and administrative expenses.
At March 31, total assets were $456,407, mainly deferred offering costs of $453,290, against liabilities of $491,418, resulting in a shareholders’ deficit of $35,011. Liquidity was provided by a non‑interest‑bearing promissory note from the sponsor and founder capital.
Subsequent to quarter-end, the SPAC completed its IPO on May 1, 2026, selling 25,000,000 units at $10.00 each for gross proceeds of $250,000,000. A total of $250,000,000 was placed into a trust account, with an additional $7,010,000 raised from private placement warrants. The SPAC has 24 months from the IPO closing to complete a business combination or redeem public shares.
RRE Ventures Acquisition Corp. reported that its 10% owner RRE Sponsor, LLC forfeited 1,250,000 Class B Ordinary Shares on May 14, 2026 for no consideration after underwriters waived their IPO over-allotment option. Following this change, the sponsor holds 5,585,333 Class B Ordinary Shares indirectly.
The Class B Ordinary Shares automatically convert into Class A Ordinary Shares at the time of the company’s initial business combination, or earlier at the sponsor’s option, on a one-for-one basis and have no expiration date. The sponsor is controlled by a three‑member board of managers, each of whom disclaims beneficial ownership except to the extent of any pecuniary interest.
RRE Ventures Acquisition Corp., a special purpose acquisition company, announced that holders of its units may begin separately trading the Class A ordinary shares and warrants on May 20, 2026. Separated shares will trade under “RREV” and warrants under “RREVW,” while unsplit units remain under “RREVU.”
No fractional warrants will be issued, and only whole warrants will trade. The company previously completed an initial public offering of 25,000,000 units on May 1, 2026, and the underwriters forfeited their over-allotment option on May 14, 2026.
RRE Ventures Acquisition Corp., a Cayman Islands-based blank check company, has completed its initial public offering of 25,000,000 units at $10.00 per unit, raising gross proceeds of $250,000,000. Each unit includes one Class A ordinary share and one-third of a redeemable warrant exercisable at $11.50 per share.
The company also sold 7,010,000 Private Placement Warrants for $7,010,000, bringing total cash raised to support a future business combination. As of May 1, 2026, $250,000,000 has been placed in a U.S. Trust Account for the benefit of public shareholders, while 25,000,000 Class A shares are classified as redeemable at $10.00 per share.
RRE Ventures Acquisition Corp. president Jeffrey Douglas Epstein reported awards of warrants and founder shares. He received 500,000 private placement warrants at a purchase price of $1.0000 per warrant, each exercisable for Class A Ordinary Shares at a conversion price of $11.5000.
He was also granted 450,000 Class B Ordinary Shares on March 2, 2026 and a further 150,000 Class B Ordinary Shares on March 18, 2026, bringing his Class B holdings to 600,000 shares. According to the filing, the Class B Ordinary Shares will automatically convert into Class A Ordinary Shares on a one-for-one basis upon the issuer’s initial business combination, or earlier at his option.
RRE Ventures Acquisition Corp. director awards via affiliated LLC show compensation-style grants rather than open-market trades. Keegan Investment Holdings, LLC, an entity associated with director Brian Frederick Daly, received 250,000 private placement warrants at $1.00 each, exercisable for Class A Ordinary Shares at $11.50 per share after the company’s initial business combination. The same LLC also received 75,000 and then an additional 30,000 Class B Ordinary Shares, which are convertible into Class A Ordinary Shares on a one-for-one basis with no expiration.
RRE Ventures Acquisition Corp. director Bruce Bernstein reported receiving equity awards in the form of warrants and Class B Ordinary Shares. On May 1, 2026, he was granted 250,000 warrants at $1.00 per warrant, each exercisable into one Class A Ordinary Share at a conversion price of $11.50 per share, bringing his warrant holdings to 250,000. Earlier awards of Class B Ordinary Shares on March 2, 2026 for 40,000 shares and on March 25, 2026 for 75,000 shares increased his Class B holdings to 115,000. The Class B shares automatically convert into Class A Ordinary Shares on a one-for-one basis at the time of the company’s initial business combination, or earlier at his option, while the private placement warrants become exercisable 30 days after that business combination and expire five years later.
RRE Ventures Acquisition Corp. director Robert Scott Mancini reported awards of derivative securities linked to Class A Ordinary Shares. He received 250,000 warrants at $1.00 per warrant, each exercisable into one Class A share at an exercise price of $11.50 after the company’s initial business combination. He also received 75,000 and 40,000 Class B Ordinary Shares at no cost, which automatically convert into Class A shares on a one-for-one basis in connection with the initial business combination or earlier at his option.
RRE Ventures Acquisition Corp. director and CEO Philip Kassin reported awards of warrants and convertible sponsor shares rather than open‑market trades. He received 250,000 private placement warrants at $1.00 per warrant, each exercisable for one Class A Ordinary Share at $11.50 per share. Earlier awards added 450,000 and 75,000 Class B Ordinary Shares, which are convertible into Class A on a one‑for‑one basis in connection with the company’s initial business combination. After these grants, he directly holds 250,000 warrants and 525,000 Class B shares, with no sales or dispositions reported.
RRE Ventures Acquisition Corp. director James Steven Gertler reported compensation-related equity grants. He received 125,000 private placement warrants on May 1, 2026 at $1.00 per warrant, each exercisable for one Class A Ordinary Share at an exercise price of $11.50. He was also awarded 30,000 Class B Ordinary Shares on March 2, 2026 and a further 37,500 Class B Ordinary Shares on March 24, 2026, taking his Class B holdings to 67,500 shares. The Class B Ordinary Shares automatically convert into Class A Ordinary Shares on a one-for-one basis at the company’s initial business combination, or earlier at his option, and the private placement warrants become exercisable 30 days after that business combination and expire five years later or earlier upon liquidation.